TABLE 3.
Adverse events after vaccination
| Type of reaction | No. (%) of patients with reaction to: |
|||||
|---|---|---|---|---|---|---|
| CoronaVac |
BNT162b2 |
|||||
| Female (n = 34) | Male (n = 19) | Total (n = 53) | Female (n = 46) | Male (n = 34) | Total (n = 80) | |
| Systemic reactions | 19 (55.9) | 4 (21.1) | 23 (43.4) | 34 (73.9) | 23 (67.6) | 57 (71.3) |
| Fever | 0 (0.0) | 0 (0.0) | 0 (0.0) | 5 (10.9) | 4 (11.8) | 9 (11.3) |
| Chills | 3 (8.8) | 0 (0.0) | 3 (5.7) | 6 (13.0) | 3 (8.8) | 9 (11.3) |
| Headache | 9 (26.5) | 0 (0.0) | 9 (17.0) | 21 (45.7) | 10 (29.4) | 31 (38.8) |
| Tiredness | 13 (38.2) | 1 (5.3) | 14 (26.4) | 27 (58.7) | 21 (61.8) | 48 (53.3) |
| Nausea | 4 (11.8) | 0 (0.0) | 4 (7.6) | 9 (19.6) | 3 (8.8) | 12 (15) |
| Vomiting | 1 (2.9) | 0 (0.0) | 1 (1.9) | 1 (2.2) | 0 (0.0) | 1 (1.3) |
| Diarrhea | 4 (11.8) | 1 (5.3) | 5 (9.4) | 6 (13.0) | 1 (2.9) | 7 (8.8) |
| Muscle pain | 8 (23.5) | 2 (10.5) | 10 (18.9) | 22 (47.8) | 13 (38.2) | 35 (43.8) |
| Joint pain | 3 (8.8) | 1 (5.3) | 4 (7.6) | 12 (26.1) | 5 (14.7) | 17 (21.3) |
| Skin rash | 1 (2.9) | 0 (0.0) | 1 (1.9) | 2 (4.4) | 1 (2.9) | 3 (3.8) |
| Local reactions | 15 (44.1) | 5 (26.3) | 20 (37.7) | 43 (93.5) | 28 (82.4) | 71 (88.8) |
| Pain | 15 (44.1) | 5 (26.3) | 20 (37.7) | 42 (91.3) | 28 (82.4) | 70 (87.5) |
| Redness | 1 (2.9) | 0 (0.0) | 1 (1.9) | 11 (23.9) | 7 (20.6) | 62 (77.5) |
| Swelling | 1 (2.9) | 0 (0.0) | 1 (1.9) | 17 (37.0) | 11 (32.4) | 28 (35) |
| Ecchymosis | 0 (0.0) | 0 (0.0) | 0 (0.0) | 5 (10.9) | 1 (2.9) | 6 (7.5) |
| Itching | 2 (5.9) | 0 (0.0) | 2 (3.8) | 8 (17.4) | 5 (14.7) | 13 (16.3) |